Nitroxide Pharmaceutical Development for Aging-Related Degeneration & Disease
Nitroxide small molecule agents are in development as preventative or therapeutic pharmaceutical drugs for age-related macular degeneration and cardiovascular disease, which are two major diseases of aging. These aging diseases are associated with patient genetics, smoking, diet, oxidative stress an...
Main Authors: | Jacob A. Zarling, Vienna E. Brunt, Anne K. Vallerga, Weixing eLi, Arnold eTao, David A. Zarling, Christopher T. Minson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-11-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2015.00325/full |
Similar Items
-
Nitroxides as antioxidants – possibilities of their application in chemoprevention and radioprotection
by: Sabina Tabaczar, et al.
Published: (2011-01-01) -
Efeito neuroprotetor do Tempol (4-hidroxi tempo) após transecção do nervo isquiático em ratos neonatos
by: Chiarotto, Gabriela Bortolança, 1989-
Published: (2013) -
Stable redox-cycling nitroxide Tempol inhibits NET formation
by: Ava eHosseinzadeh, et al.
Published: (2012-12-01) -
Cyclic nitroxides inhibit the toxicity of nitric oxide-derived oxidants: mechanisms and implications
by: Ohara Augusto, et al.
Published: (2008-03-01) -
Nitrate ammonification by Nautilia profundicola AmH: experimental evidence consistent with a free hydroxylamine intermediate.
by: Thomas E Hanson, et al.
Published: (2013-07-01)